BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du F, Liu Y. Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer. J Clin Lab Anal 2021;:e24141. [PMID: 34817097 DOI: 10.1002/jcla.24141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ware MB, Wolfarth AA, Goon JB, Ezeanya UI, Dhar S, Ferrando-martinez S, Lee BH. The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers. Journal of Immunotherapy and Precision Oncology 2022;5:105-117. [DOI: 10.36401/jipo-22-10] [Reference Citation Analysis]
2 Ho V, Chung L, Lim SH, Ma Y, Wang B, Lea V, Abubakar A, Ng W, Lee M, Roberts TL, Chua W, Lee CS. Prognostic Impact of TP53 Mutations and Tumor Mutational Load in Colorectal Cancer. Gastrointestinal Disorders 2022;4:165-179. [DOI: 10.3390/gidisord4030016] [Reference Citation Analysis]
3 Yu IS, Aubin F, Goodwin R, Loree JM, Mather C, Sheffield BS, Snow S, Gill S. Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline. Ther Adv Med Oncol 2022;14:17588359221111705. [PMID: 35898967 DOI: 10.1177/17588359221111705] [Reference Citation Analysis]
4 Solis Soto LM, Wang H. Implications of Tumor Immune Microenvironment and Molecular Markers for Cancer Immunotherapy. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_115-1] [Reference Citation Analysis]
5 Alqahtani SM. Molecular Neuropathology versus Histopathology in the Diagnosis of Central Nervous System Tumors: Review Article about Novel Diagnostic and Investigative Technologies. JBM 2022;10:55-72. [DOI: 10.4236/jbm.2022.1012006] [Reference Citation Analysis]